SAN JOSE — A biotech firm with a global reach has bought a big North San Jose tech building in a deal that shows at least some office buildings can capture higher values even in the face of ...
Bio-Techne (TECH) prevailed on another claim that Miltenyi Biotec KG commercialized antibodies developed based on information obtained by reverse engineering Bio-Techne’s proprietary R&D Systems ...
In this webinar, Evelien Van Hamme and Elina Kuznecova will discuss core facility perspectives and their experiences with the MACSima spatial proteomics platform at the Flemish Institute for ...
Hosted on MSN
Miltenyi Biotec's ZAMTO Cell, claimed to be India's first dual-target CAR-T cancer therapy, expected by 2026
German biotechnology company Miltenyi Biotec has said that its CAR-T therapy, ZAMTO Cell, for B-cell lymphoma, is expected to be available in India by early 2026. CAR-T (Chimeric Antigen Receptor ...
Hosted on MSN
BIRAC in pact with Miltenyi Biotec India to boost India's capabilities in cell & gene therapy
HYDERABAD: In a move aimed at beefing up India’s leadership in cutting-edge biotherapeutics such as cell and gene therapy (CGT), the Biotechnology Industry Research Assistance Council (BIRAC) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback